Verici Dx has received approval from the state of New York, which may establish nationwide access to its Tutivia kidney transplant rejection test. However, it is unclear if Verici Dx or another company, DELFI Diagnostics, received the approval. The approval is related to a laboratory permit, which would allow the company to serve health systems across the US.